StockData
GENELUX Corp logo

GENELUX Corp (GNLX) stock

GNLXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30
$2.17−0.11 (-4.82%)

Close on Nov 20, 2026Market cap $98.18MP/E –Yield –

Genelux gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Genelux

Genelux has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Genelux figures

See a number that looks wrong?